{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:34:09Z","timestamp":1789929249639,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Fondecyt","award":["1171213"],"award-info":[{"award-number":["1171213"]}]},{"name":"Fondecyt","award":["11160380"],"award-info":[{"award-number":["11160380"]}]},{"DOI":"10.13039\/501100008736","name":"Fondef","doi-asserted-by":"crossref","award":["ID16i10148"],"award-info":[{"award-number":["ID16i10148"]}],"id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013928","name":"MIII","doi-asserted-by":"crossref","award":["P09\/016-F"],"award-info":[{"award-number":["P09\/016-F"]}],"id":[{"id":"10.13039\/501100013928","id-type":"DOI","asserted-by":"crossref"}]},{"name":"(CONICYT)-PCHA\/Doctorado Nacional","award":["21130465"],"award-info":[{"award-number":["21130465"]}]},{"name":"CONICYT-PAI\/TESIS DOCTORADO SECTOR PRODUCTIVO","award":["7815110008"],"award-info":[{"award-number":["7815110008"]}]},{"name":"FONDECYT POSTDOCTORADO","award":["3170917"],"award-info":[{"award-number":["3170917"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4147-6","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T04:21:56Z","timestamp":1519964516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["High CD8+ and absence of Foxp3+ T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival"],"prefix":"10.1186","volume":"18","author":[{"given":"Paula","family":"Flux\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rojas-Sep\u00falveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Alejandra","family":"Gleisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Tittarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes Natalia","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Cat\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Salazar-Onfray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"key":"4147_CR1","first-page":"99","volume":"6","author":"R Hundal","year":"2014","unstructured":"Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99\u2013109.","journal-title":"Clin Epidemiol"},{"key":"4147_CR2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359\u201386.","journal-title":"Int J Cancer"},{"key":"4147_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1309\/AJCPQT3ELN2BBCKA","volume":"141","author":"I Roa","year":"2014","unstructured":"Roa I, Ibacache G, Mu\u00f1oz S, de Aretxabala X. Gallbladder cancer in Chile: pathologic characteristics of survival and prognostic factors: analysis of 1,366 cases. Am J Clin Pathol. 2014;141:675\u201382.","journal-title":"Am J Clin Pathol"},{"key":"4147_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/MOG.0000000000000164","volume":"31","author":"I Roa","year":"2015","unstructured":"Roa I, de Aretxabala X. Gallbladder cancer in Chile: what have we learned? Curr Opin Gastroenterol. 2015;31:269\u201375.","journal-title":"Curr Opin Gastroenterol"},{"key":"4147_CR5","first-page":"1040","volume":"114","author":"G Smok","year":"1986","unstructured":"Smok G, Cervilla K. Carcinoma of the gallbladder: analysis of 373 cases. Rev Med Chil. 1986;114:1040\u20136.","journal-title":"Rev Med Chil"},{"key":"4147_CR6","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1572-0241.2000.02070.x","volume":"95","author":"S Sheth","year":"2000","unstructured":"Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol. 2000;95:1402\u201310.","journal-title":"Am J Gastroenterol"},{"key":"4147_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1200\/JCO.2008.18.0794","volume":"27","author":"MN L\u00f3pez","year":"2009","unstructured":"L\u00f3pez MN, Pereda C, Segal G, Mu\u00f1oz L, Aguilera R, Gonz\u00e1lez FE, et al. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor \u03b2-expressing T cells. J Clin Oncol. 2009;27:945\u201352.","journal-title":"J Clin Oncol"},{"key":"4147_CR8","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1158\/1078-0432.CCR-10-2384","volume":"17","author":"R Aguilera","year":"2011","unstructured":"Aguilera R, Saffie C, Tittarelli A, Gonz\u00e1lez FE, Ram\u00edrez M, Reyes D, et al. Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells. Clin Cancer Res. 2011;17:2474\u201383.","journal-title":"Clin Cancer Res"},{"key":"4147_CR9","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/bjc.2013.494","volume":"109","author":"D Reyes","year":"2013","unstructured":"Reyes D, Salazar L, Espinoza E, Pereda C, Castell\u00f3n E, Valdevenito R, et al. Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients. Br J Cancer. 2013;109:1488\u201397.","journal-title":"Br J Cancer"},{"key":"4147_CR10","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960\u20134.","journal-title":"Science"},{"key":"4147_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, et al. Intratumoural T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003;348:203\u201313.","journal-title":"N Engl J Med"},{"key":"4147_CR12","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","volume":"29","author":"SM Mahmoud","year":"2011","unstructured":"Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AH, et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol. 2011;29:1949\u201355.","journal-title":"J Clin Oncol"},{"key":"4147_CR13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1158\/1078-0432.498.11.2","volume":"11","author":"E Ryschich","year":"2005","unstructured":"Ryschich E, N\u00f6tzel T, Hinz U, Autschbach F, Ferguson J, Simon I, et al. Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma. Clin Cancer Res. 2005;11:498\u2013504.","journal-title":"Clin Cancer Res"},{"key":"4147_CR14","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1038\/bjc.2013.610","volume":"109","author":"B Goeppert","year":"2013","unstructured":"Goeppert B, Frauenschuh L, Zucknick M, Stenzinger A, Andrulis M, Klauschen F, et al. Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer. Br J Cancer. 2013;109:2665\u201374.","journal-title":"Br J Cancer"},{"key":"4147_CR15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/IGC.0b013e3182131f36","volume":"21","author":"JJ Sznurkowski","year":"2011","unstructured":"Sznurkowski JJ, Zawrocki A, Emerich J, Biernat W. Prognostic significance of CD4+ and CD8+ T cell infiltration within cancer cell nests in vulvar squamous cell carcinoma. Int J Gynecol Cancer. 2011;21:717\u201321.","journal-title":"Int J Gynecol Cancer"},{"key":"4147_CR16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/WCO.0000000000000251","volume":"28","author":"M Bie\u0144kowski","year":"2015","unstructured":"Bie\u0144kowski M, Preusser M. Prognostic role of tumor-infiltrating inflammatory cells in brain tumors: literature review. Curr Opin Neurol. 2015;28:647\u201358.","journal-title":"Curr Opin Neurol"},{"key":"4147_CR17","doi-asserted-by":"publisher","first-page":"8633","DOI":"10.1073\/pnas.96.15.8633","volume":"96","author":"D Mumberg","year":"1999","unstructured":"Mumberg D, Monach PA, Wanderling S, Philip M, Toledano AY, Schreiber RD. Schreiber H. CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma. Proc Natl Acad Sci U S A. 1999;96:8633\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4147_CR18","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.4049\/jimmunol.166.4.2276","volume":"166","author":"G Beatty","year":"2001","unstructured":"Beatty G, Paterson Y. IFN-gamma-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-gamma. J Immunol. 2001;166:2276\u201382.","journal-title":"J Immunol"},{"key":"4147_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.coi.2007.02.004","volume":"19","author":"HY Wang","year":"2007","unstructured":"Wang HY, Wang RF. Regulatory T cells and cancer. Curr Opin Immunol. 2007;19:217\u201323.","journal-title":"Curr Opin Immunol"},{"key":"4147_CR20","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057\u201361.","journal-title":"Science"},{"key":"4147_CR21","doi-asserted-by":"publisher","first-page":"164fs44","DOI":"10.1126\/scitranslmed.3005283","volume":"4","author":"PD Bos","year":"2012","unstructured":"Bos PD, Rudensky AY. Treg cells in cancer: a case of multiple personality disorder. Sci Transl Med. 2012;4:164fs44.","journal-title":"Sci Transl Med"},{"key":"4147_CR22","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1158\/1078-0432.CCR-05-2434","volume":"12","author":"GG Grabenbauer","year":"2006","unstructured":"Grabenbauer GG, Lahmer G, Distel L, Niedobitek G. Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. Clin Cancer Res. 2006;12:3355\u201360.","journal-title":"Clin Cancer Res"},{"key":"4147_CR23","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00432-010-0816-9","volume":"136","author":"Z Shen","year":"2010","unstructured":"Shen Z, Zhou S, Wang Y, Li RL, Zhong C, Liang C, Sun Y. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+\/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol. 2010;136:1585\u201395.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4147_CR24","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1097\/PAS.0b013e31824e9b7c","volume":"36","author":"AM Mathai","year":"2012","unstructured":"Mathai AM, Kapadia MJ, Alexander J, Kernochan LE, Swanson PE, Yeh MM. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma. Am J Surg Pathol. 2012;36:980\u20136.","journal-title":"Am J Surg Pathol"},{"key":"4147_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jso.10321","volume":"84","author":"T Oshikiri","year":"2003","unstructured":"Oshikiri T, Miyamoto M, Shichinohe T, Suzuoki M, Hiraoka K, Nakakubo Y, et al. Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response. J Surg Oncol. 2003;84:224\u20138.","journal-title":"J Surg Oncol"},{"key":"4147_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.humpath.2004.03.016","volume":"35","author":"S Takagi","year":"2004","unstructured":"Takagi S, Miyagawa S, Ichikawa E, Soeda J, Miwa S, Miyagawa Y, et al. Dendritic cells, T-cell infiltration, and Grp94 expression in cholangiocellular carcinoma. Hum Pathol. 2004;35:881\u20136.","journal-title":"Hum Pathol"},{"key":"4147_CR27","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1158\/1078-0432.CCR-06-0369","volume":"12","author":"N Hiraoka","year":"2006","unstructured":"Hiraoka N, Onozato K, Kosuge T, Hirohashi S. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res. 2006;12:5423\u201334.","journal-title":"Clin Cancer Res"},{"key":"4147_CR28","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/bjc.2013.32","volume":"108","author":"Y Ino","year":"2013","unstructured":"Ino Y, Yamazaki-Itoh R, Shimada K, Iwasaki M, Kosuge T, Kanai Y, Hiraoka N. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer. 2013;108:914\u201323.","journal-title":"Br J Cancer"},{"key":"4147_CR29","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/sj.bjc.6601331","volume":"89","author":"Y Nakakubo","year":"2003","unstructured":"Nakakubo Y, Miyamoto M, Cho Y, Hida Y, Oshikiri T, Suzuoki M, et al. Clinical significance of immune cell infiltration within gallbladder cancer. Br J Cancer. 2003;89:1736\u201342.","journal-title":"Br J Cancer"},{"key":"4147_CR30","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/cas.12825","volume":"106","author":"S Oguro","year":"2015","unstructured":"Oguro S, Ino Y, Shimada K, Hatanaka Y, Matsuno Y, Esaki M, et al. Clinical significance of tumor-infiltrating immune cells focusing on BTLA and Cbl-b in patients with gallbladder cancer. Cancer Sci. 2015;106:1750\u201360.","journal-title":"Cancer Sci"},{"key":"4147_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00262-003-0388-5","volume":"52","author":"AC Diederichsen","year":"2003","unstructured":"Diederichsen AC, Hjelmborg JV, Christensen PB, Zeuthen J, Fenger C. Prognostic value of the CD4+\/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother. 2003;52:423\u20138.","journal-title":"Cancer Immunol Immunother"},{"key":"4147_CR32","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/bjc.2015.337","volume":"113","author":"B Goeppert","year":"2015","unstructured":"Goeppert B, Frauenschuh L, Zucknick M, Roessler S, Mehrabi A, Hafezi M, et al. Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer. Br J Cancer. 2015;113:1343\u20139.","journal-title":"Br J Cancer"},{"key":"4147_CR33","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/sji.12109","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Huang Y, Qin M. Tumour-infiltrating Foxp3+ and IL-17-producing T cells affect the progression and prognosis of gallbladder carcinoma after surgery. Scand J Immunol. 2013;78:516\u201322.","journal-title":"Scand J Immunol"},{"key":"4147_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/annonc\/mdn533","volume":"20","author":"G Randi","year":"2009","unstructured":"Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S, La Vecchia C. Epidemiology of biliary tract cancers: an update. Ann Oncol. 2009;20:146\u201359.","journal-title":"Ann Oncol"},{"key":"4147_CR35","first-page":"245","volume":"1865","author":"JA Espinoza","year":"2016","unstructured":"Espinoza JA, Bizama C, Garc\u00eda P, Ferreccio C, Javle M, Miquel JF, et al. The inflammatory inception of gallbladder cancer. Biochim Biophys Acta. 2016;1865:245\u201354.","journal-title":"Biochim Biophys Acta"},{"key":"4147_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrc1429","volume":"4","author":"II Wistuba","year":"2004","unstructured":"Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4:695\u2013706.","journal-title":"Nat Rev Cancer"},{"key":"4147_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4067\/S0034-98872014000300001","volume":"142","author":"M Fuentes","year":"2014","unstructured":"Fuentes M, Pulgar I, Gallo C, Bortolini MC, Canizales-Quinteros S, Bedoya G, et al. Gene geography of Chile: regional distribution of American, European and African genetic contributions. Rev Med Chil. 2014;142:281\u20139.","journal-title":"Rev Med Chil"},{"key":"4147_CR38","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3748\/wjg.v22.i4.1335","volume":"22","author":"EI Marks","year":"2016","unstructured":"Marks EI, Yee NS. Molecular genetics and targeted therapeutics in biliary tract carcinoma. World J Gastroenterol. 2016;22:1335\u201347.","journal-title":"World J Gastroenterol"},{"key":"4147_CR39","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1007\/s13277-015-4743-x","volume":"37","author":"Y Chai","year":"2016","unstructured":"Chai Y. Immunotherapy of biliary tract cancer. Tumour Biol. 2016;37:2817\u201321.","journal-title":"Tumour Biol"},{"key":"4147_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00534-011-0437-y","volume":"19","author":"K Shimizu","year":"2012","unstructured":"Shimizu K, Kotera Y, Aruga A, Takeshita N, Takasaki K, Yamamoto M. Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2012;19:171\u20138.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"4147_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-008-0568-4","volume":"58","author":"L Engell-Noerregaard","year":"2009","unstructured":"Engell-Noerregaard L, Hansen TH, Andersen MH, Thor Straten P, Svane IM. Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters. Cancer Immunol Immunother. 2009;58:1\u201314.","journal-title":"Cancer Immunol Immunother"},{"key":"4147_CR42","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00262-004-0629-2","volume":"54","author":"L H\u00f6ltl","year":"2005","unstructured":"H\u00f6ltl L, Ramoner R, Zelle-Rieser C, Gander H, Putz T, Papesh C, et al. Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide. Cancer Immunol Immunother. 2005;54:663\u201370.","journal-title":"Cancer Immunol Immunother"},{"key":"4147_CR43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/vaccines3020344","volume":"3","author":"CL Chiang","year":"2015","unstructured":"Chiang CL, Coukos G, Kandalaft LE. Whole tumor antigen vaccines: where are we? Vaccines (Basel). 2015;3:344\u201372.","journal-title":"Vaccines (Basel)"},{"key":"4147_CR44","first-page":"550","volume":"10","author":"JJ Skitzki","year":"2009","unstructured":"Skitzki JJ, Repasky EA, Evans EE. Hyperthermia as an immunotherapy strategy for cancer. Curr Opin Investig Drugs. 2009;10:550\u20138.","journal-title":"Curr Opin Investig Drugs"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4147-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T03:37:07Z","timestamp":1660534627000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4147-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4147"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4147-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,2]]},"assertion":[{"value":"19 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in agreement with the Helsinki Declaration and approved by the Bioethical Committee for Human Research of the Faculty of Medicine, University of Chile (ID number: 078\u20132008). All patients signed a letter of informed consent to participate at the time of surgery.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"243"}}